Journal Mobile Options
Table of Contents
Vol. 25, No. 1, 2009
Issue release date: August 2009
Fetal Diagn Ther 2009;25:47–53

Lower Extremity Neuromotor Function and Short-Term Ambulatory Potential following in utero Myelomeningocele Surgery

Danzer E. · Gerdes M. · Bebbington M.W. · Sutton L.N. · Melchionni J. · Adzick N.S. · Wilson R.D. · Johnson M.P.
Center for Fetal Diagnosis and Treatment, Children’s Hospital of Philadelphia and University of Pennsylvania School of Medicine, Philadelphia, Pa., USA

Individual Users: Register with Karger Login Information

Please create your User ID & Password

Contact Information

I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in


Objective: To evaluate lower extremity neuromotor function (LENF) and short-term ambulatory potential following fetal myelomeningocele (fMMC) closure. Methods: Retrospective chart review of 54 children that underwent fMMC closure at our institution prior to the NIHCD-MOMS trial. Neonatal LENF was compared to predicted function based on spinal lesion level assigned by prenatal ultrasound. Ambulatory status was classified as independent walkers (walks without assistive appliances), assisted walker (requires walking aid), and non-ambulatory (wheelchair bound). Results: Thoracic, lumbar, and sacral level lesions were present in 4, 44 and 6 fMMC infants, respectively. 31/54 of fMMC children (57.4%; median: 2 levels, range: 1–5) had better than predicted, 13/54 (24.1%) same as predicted and 10/54 (18.5%; median: 1 level, range: 1–2) worse than predicted LENF at birth. At a median follow-up age of 66 months (36–113), 37/54 (69%) walk independently, 13/54 (24%) are assisted walkers, and 4/54 (7%) are wheelchair dependent. The strongest factors predicting a lower likelihood to walk independently were higher-level lesion (>L4, p = 0.001) and the development of clubfoot deformity after fetal intervention (p = 0.026). Despite the observed improved ambulatory status, structured evaluation of coordinative skills revealed that the majority of independent ambulators and all children that require assistive devices to walk experience significant deficits in lower extremity coordination. Conclusions: We observed that fMMC surgery in this highly selective population results in better than predicted LENF at birth and short-term ambulatory status. However, fMMC toddlers continue to demonstrate deficits in movement coordination that are characteristic for children with spina bifida.

Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.


  1. Korenromp MJ, van Gool JD, Bruinese HW, Kriek R: Early fetal leg movements in myelomeningocele. Lancet 1986;i:917–918.

    External Resources

  2. Sival DA, Begeer JH, Staal-Schreinemachers AL, Vos-Niel JM, Beekhuis JR, Prechtl HF: Perinatal motor behaviour and neurological outcome in spina bifida aperta. Early Human Dev 1997;50:27–37.
  3. Warsof SL, Abromwicz JS, Sayegh SK, Levy DL: Lower limb movements and urologic function in fetuses with neural tube and other central nervous system defects. Fetal Ther 1988;3:129–134.
  4. Hutchins GM, Meuli M, Meuli-Simmen C, Jordan MA, Heffez DS, Blakemore KJ: Acquired spinal cord injury in human fetuses with myelomeningocele. Pediatr Path Lab Med 1996;16:701–712.
  5. Meuli M, Meuli-Simmen C, Hutchins GM, Seller MJ, Harrison MR, Adzick NS: The spinal cord lesion in human fetuses with myelomeningocele: implications for fetal surgery. J Pediatr Surg 1997;31:448–452.

    External Resources

  6. Meuli M, Meuli-Simmen C, Hutchins GM, Yingling CD, Hoffman KM, Harrison MR, Adzick NS: In utero surgery rescues neurological function at birth in sheep with spina bifida. Nat Med 1995;1:342–347.
  7. Adzick NS, Sutton LS, Crombleholme TM, Flake AW: Successful fetal surgery for spina bifida. Lancet 1998;352:1675–1676.
  8. Sutton LN, Adzick NS, Bilaniuk LT, Johnson MP, Crombleholme TM, Flake AW: Improvement in hindbrain herniation demonstrated by serial fetal magnetic resonance imaging following fetal surgery for myelomeningocele. JAMA 1999;282:1826–1831.
  9. Bruner JP, Tulipan N, Paschall RL, Boehm FH, Walsh WF, Silva SR, Hernanz Schulman M, Lowe LH, Reed GW: Fetal surgery for myelomeningocele and the incidence of shunt-dependent hydrocephalus. JAMA 1999;282:1819–1825.
  10. Johnson MP, Adzick NS, Rintoul N, Crombleholme TM, Adzick NS, Flake AW: Fetal myelomeningocele repair: short-term clinical outcomes. Am J Obstet Gynecol 2003;189:482–487.
  11. Danzer E, Johnson MP, Wilson RD, Flake AW, Hedrick HL, Sutton LN, Adzick NS: Fetal head biometry following in-utero repair of myelomeningocele. Ultrasound Obstet Gynecol 2004;24:606–611.
  12. Johnson MP, Gerdes M, Rintoul N, Pasquariello P, Melchionni J, Sutton LN, Adzick NS: Maternal-fetal surgery for myelomeningocele: neurodevelopmental outcomes at 2 years of age. Am J Obstet Gynecol 2006;194:1145–1152.
  13. Danzer E, Johnson MP, Bebbington M, Simon EM, Wilson RD, Bilaniuk LT, Sutton LN, Adzick NS: Fetal head biometry assessed by fetal magnetic resonance imaging following in utero myelomeningocele repair. Fetal Diagn Ther 2007;22:1–6.
  14. Coniglio SJ, Anderson SM, Ferguson JE: Functional motor outcome in children with myelomeningocele: correlation with anatomic level on prenatal ultrasound. Dev Med Child Neurol 1996;38:675–680.
  15. Kendall FP, McCreasy EK, Provance PG: Muscles: Testing and Functions, ed 4. Baltimore, Williams & Wilkins, 1993.
  16. Rintoul NE, Sutton LN, Hubbard AM, Cohen B, Melchionni J, Pasquariello PS, Adzick NS: A new look at myelomeningoceles: functional level, vertebral level, shunting, and the implication for fetal intervention. Pediatrics 2002;109:409–413.
  17. Tulipan N, Bruner JB, Hernanz-Schulman M, Lowe LH, Walsh WF, Nickolaus D, Oakes WJ: Effects of intrauterine myelomeningocele repair on central nervous systems structure and function. Pediatr Neurosurg 1999;31:183–188.
  18. Tubbs RS, Chambers MR, Smyth MD, Bartolucci AA, Bruner JP, Tulipan N, Oakes WJ: Late gestational intrauterine myelomeningocele repair does not improve lower extremity function. Pediatr Neurosurg 2003;38:128–132.
  19. Stiefel D, Copp AJ, Meuli M: Fetal spina bifida in a mouse model: loss of neural function in utero. J Neurosurg 2007;106:213–221.
  20. Biggio JR, Owen J, Wenstrom KD, Oakes WJ: Can prenatal ultrasound findings predict ambulatory status in fetuses with open spina bifida? Am J Obstet Gynecol 2001;185:1016–1020.
  21. Rendeli C, Salvaggio E, Sciacia Cannizzaro G, Bianchi E, Caldarelli M, Guzzetta F: Does locomotion improve the cognitive profile of children with meningomyelocele. Childs Nerv Syst 2002;18:231–234.
  22. Steinbok P, Irvine B, Cochrane DD, Irwin BJ: Long-term outcome and complication of children born with meningomyelocele. Childs Nerv Syst 1992;8:92–96.
  23. Norrlin S, Strinnholm M, Carlsson M, Dahl M: Factors of significance for mobility in children with myelomeningocele. Acta Paediatr 2003;92:204–210.
  24. Williams EN, Broughton NS, Menelaus MB: Age-related walking in children with spina bifida. Dev Med Child Neurol 1999;41:446–449.
  25. Cochrane D, Arynyk K, Sawatzky B, Wilson D, Steinbok: The effects of labor and delivery on spinal cord function and ambulation in patients with meningomyelocele. Childs Nerv Syst 1991;7:312–315.
  26. Kollias SS, Goldstein RB, Cogen PH, Filly RA: Prenatally detected myelomeningoceles: sonographic accuracy in estimation of the spinal levels. Radiology 1992;185:109–112.
  27. Bowmann RM, McLone DG, Grant JA, Ito JA: Spina bifida outcome: a 25-year prospective. Pediatric Neurosurg 2001;34:114–120.
  28. Sival DA, van Weerden TW, Vles JS, Timmer A, den Dunnen WF, Staal-Schreinemachers AL, Hoving EW, Sollie KM, Kranen-Mastenbroek VJ, Sauer PJ, Brouwer OF: Neonatal loss of motor function in human spina bifida aperta. Pediatrics 2004;114:427–434.
  29. Sival DA, Brouwer OF, Bruggink JL, Vles JS, Staal-Schreinemachers AL, Sollie KM, Sauer PJ, Bos AF: Movement analysis in neonates with spina bifida aperta. Early Hum Dev 2006;82:227–234.
  30. McDonald CM, Jaffe KM, Shurtleff DB: Assessment of muscle strength in children with myelomeningocele: accuracy and stability of measurements over time. Arch Phys Med Rehabil 1986;67:855–861.
  31. Schoenmakers MA, Uiterwall CS, Gulmans VA, Gooskens RH, Helders PJ: Determinants of functional independence and quality of life in children with spina bifida. Clin Rehabil 2005;19:677–685.
  32. Williams MA, Thomas G, de Lateur B, Imteyaz H, Rose JG, Shore WS, Kharkar S, Rigamonti D: Objective assessment of gait in normal-pressure hydrocephalus. Am J Phys Med Rehabil 2007;12:1–7.

Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50